Personensuche
X
?
1
Pulmonary TB in progressor DO mice reflects acute inflammat..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/journal_contribution/Pulmonary_TB_in_progressor_DO_mice_reflects_acute_inflammation_neutrophil_recruitment_and_activation_and_extracellular_matrix_degradation_/15182806. , 2021
https://figshare.com/articles/journal_contribution/Pulmonary_TB_in_progressor_DO_mice_reflects_acute_inflammation_neutrophil_recruitment_and_activation_and_extracellular_matrix_degradation_/15182806. , 2021
?
2
The AUC values of the ten biomarkers in the discovery cohor..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/journal_contribution/The_AUC_values_of_the_ten_biomarkers_in_the_discovery_cohort_for_classifying_between_progressor_and_controller_mice_/15182830. , 2021
https://figshare.com/articles/journal_contribution/The_AUC_values_of_the_ten_biomarkers_in_the_discovery_cohort_for_classifying_between_progressor_and_controller_mice_/15182830. , 2021
?
3
Serum protein biomarker AUC analyses in human patient sera:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/dataset/Serum_protein_biomarker_AUC_analyses_in_human_patient_sera_/15182908. , 2021
https://figshare.com/articles/dataset/Serum_protein_biomarker_AUC_analyses_in_human_patient_sera_/15182908. , 2021
?
4
File contains Supplementary Methods, Supplementary Text and..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/journal_contribution/File_contains_Supplementary_Methods_Supplementary_Text_and_Supplementary_References_/15182854. , 2021
https://figshare.com/articles/journal_contribution/File_contains_Supplementary_Methods_Supplementary_Text_and_Supplementary_References_/15182854. , 2021
?
5
The 100-fold-CV performance of the 478 classifiers that are..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/dataset/The_100-fold-CV_performance_of_the_478_classifiers_that_are_searched_during_the_second_classifier_selection_/15182848. , 2021
https://figshare.com/articles/dataset/The_100-fold-CV_performance_of_the_478_classifiers_that_are_searched_during_the_second_classifier_selection_/15182848. , 2021
?
6
Classifiers using lung protein biomarker candidates CXCL1, ..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/figure/Classifiers_using_lung_protein_biomarker_candidates_CXCL1_CXCL2_or_MMP8_have_the_highest_performance_/15182890. , 2021
https://figshare.com/articles/figure/Classifiers_using_lung_protein_biomarker_candidates_CXCL1_CXCL2_or_MMP8_have_the_highest_performance_/15182890. , 2021
?
7
MMP8, CXCL1 and S100A8 protein levels in human sera from pa..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/figure/MMP8_CXCL1_and_S100A8_protein_levels_in_human_sera_from_patients_with_active_pulmonary_TB_ATB_latent_i_Mtb_i_infection_LTBI_non-TB_disease_and_normal_individuals_/15182896. , 2021
https://figshare.com/articles/figure/MMP8_CXCL1_and_S100A8_protein_levels_in_human_sera_from_patients_with_active_pulmonary_TB_ATB_latent_i_Mtb_i_infection_LTBI_non-TB_disease_and_normal_individuals_/15182896. , 2021
?
8
Receiver Operating Characteristics (ROC) curves of classifi..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/figure/Receiver_Operating_Characteristics_ROC_curves_of_classifier_performance_to_diagnose_progressor_i_Mtb_i_-infected_DO_mice_/15182884. , 2021
https://figshare.com/articles/figure/Receiver_Operating_Characteristics_ROC_curves_of_classifier_performance_to_diagnose_progressor_i_Mtb_i_-infected_DO_mice_/15182884. , 2021
?
9
Flow chart of sample organization and datasets:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/figure/Flow_chart_of_sample_organization_and_datasets_/15182878. , 2021
https://figshare.com/articles/figure/Flow_chart_of_sample_organization_and_datasets_/15182878. , 2021
?
10
Feature rankings of the ten biomarkers:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/journal_contribution/Feature_rankings_of_the_ten_biomarkers_/15182824. , 2021
https://figshare.com/articles/journal_contribution/Feature_rankings_of_the_ten_biomarkers_/15182824. , 2021
?
11
Confusion matrices for the biomarkers in human sera:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/figure/Confusion_matrices_for_the_biomarkers_in_human_sera_/15182794. , 2021
https://figshare.com/articles/figure/Confusion_matrices_for_the_biomarkers_in_human_sera_/15182794. , 2021
?
12
The 5-fold-CV AUC values of the 478 classifiers that are se..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/dataset/The_5-fold-CV_AUC_values_of_the_478_classifiers_that_are_searched_during_the_first_classifier_selection_/15182842. , 2021
https://figshare.com/articles/dataset/The_5-fold-CV_AUC_values_of_the_478_classifiers_that_are_searched_during_the_first_classifier_selection_/15182842. , 2021
?
13
S3 Fig -:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/figure/S3_Fig_-/15182800. , 2021
https://figshare.com/articles/figure/S3_Fig_-/15182800. , 2021
?
14
The 100-fold-Cross Validation (CV) performance of the three..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/journal_contribution/The_100-fold-Cross_Validation_CV_performance_of_the_three_classifiers_that_satisfy_the_criterion_for_both_leave-one-experiment-out_and_four-experiments-combined_settings_/15182818. , 2021
https://figshare.com/articles/journal_contribution/The_100-fold-Cross_Validation_CV_performance_of_the_three_classifiers_that_satisfy_the_criterion_for_both_leave-one-experiment-out_and_four-experiments-combined_settings_/15182818. , 2021
?
15
5-fold-Cross Validation (CV) results of the initial selecti..:
Deniz Koyuncu (11285923) ; Muhammad Khalid Khan Niazi (5095121) ; Thomas Tavolara (11285926)...
https://figshare.com/articles/journal_contribution/5-fold-Cross_Validation_CV_results_of_the_initial_selection_/15182812. , 2021
https://figshare.com/articles/journal_contribution/5-fold-Cross_Validation_CV_results_of_the_initial_selection_/15182812. , 2021